What is the Market's View on Aadi Bioscience Inc (AADI) Stock's Price and Volume Trends Wednesday?

The market has been high on Aadi Bioscience Inc (AADI) stock recently. AADI gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Aadi Bioscience Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on AADI!

See Full AADI Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With AADI Stock Today?

Aadi Bioscience Inc (AADI) stock is trading at $13.53 as of 1:19 PM on Wednesday, Aug 3, a gain of $0.09, or 0.71% from the previous closing price of $13.43. The stock has traded between $13.31 and $14.19 so far today. Volume today is light. So far 39,617 shares have traded compared to average volume of 190,510 shares. To see InvestorsObserver's Sentiment Score for Aadi Bioscience Inc click here.

More About Aadi Bioscience Inc

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. Click Here to get the full Stock Report for Aadi Bioscience Inc stock.